Tag: GSK

  • Unilever says GSK consumer arm ‘strong strategic fit’ for business

    Unilever says GSK consumer arm ‘strong strategic fit’ for business

    Dove soap maker Unilever signaled on Monday it would pursue a deal for GlaxoSmithKline’s consumer health business, calling it a “strong strategic fit” after its 50-billion-pound approach ($68.4 billion) was rejected.

    The update comes after GSK confirmed over the weekend that it had rejected the Unilever offer for its consumer healthcare business, which is home to brands such as Sensodyne toothpaste and Emergen-C vitamin supplement.

    “The acquisition would create scale and a growth platform for the combined portfolio in the U.S., China and India, with further opportunities in other emerging markets,” Unilever said, pointing to synergies in the oral care and vitamin supplements business.

    Unilever held talks with banks about additional financing for a potential sweetened offer for GSK’s consumer products division, Bloomberg News reported on Sunday, citing people familiar with the matter.

    Unilever, which is set to announce an initiative later this month to strengthen its business, said on Monday it was committed to “strict financial discipline” for any acquisitions.

  • GSK plans to split into 2 as part of Pfizer joint venture

    GSK plans to split into 2 as part of Pfizer joint venture

    GlaxoSmithKline (GSK) plans to split into two businesses – one for prescription drugs and vaccines, the other for over-the-counter products – after forming a new joint venture with Pfizer’s consumer health division. The revamp is the boldest move yet by Emma Walmsley, the GSK chief executive who took over last year.

    It will lead to the creation of a consumer health giant with a market share of 7.3 percent, well ahead of its nearest rivals Johnson & Johnson, Bayer and Sanofi, all at around 4 percent.

    Walmsley has previously played down the idea of breaking up the group, something that a number of investors have called for over the years.

    On Wednesday, however, she announced that GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 percent owned by the British company, in an all-equity transaction.

    GSK said the deal laid the foundation for the creation of two new U.K.-based global companies focused on pharma, vaccines and consumer health care within three years of the transaction closing.

    For Pfizer, the deal resolves the issue of what to do with its consumer health division, which includes Advil painkillers and Centrum vitamins, after an abortive attempt to sell it outright earlier this year.

    GSK – whose consumer products include Sensodyne toothpaste and Panadol painkillers – had withdrawn from that earlier Pfizer auction process, but Walmsley said the opportunity to strike an all-equity deal cleared the way for the new agreement.

    “It’s something we’ve been able to do quickly and quietly,” she said.

    “What this deal is all about is the opportunity to strengthen two businesses – a world-leading consumer health care business, and a new GSK that is focused on pharma and vaccines.”

    Shareholders welcomed the news and the shares jumped 7 percent, with Jefferies analysts saying the future separation could crystallize value.

    The new joint venture with Pfizer is expected to generate total annual cost savings of 500 million pounds by 2022 for expected total cash costs of 900 million and non-cash charges of 300 million. GSK plans divestments of some 1 billion pounds.

  • World’s biggest brands put on notice over 5,000,000-tonne laminate packaging problem

    World’s biggest brands put on notice over 5,000,000-tonne laminate packaging problem

    Big brands have been put on notice about their inaction over the world’s growing 5,000,000-tonne problem of plastic aluminium laminate waste.

    Following revelations about the scale of the problem in the UK and internationally, the CEO of the company behind the world’s only solution for recycling laminates – food pouches, pet food pouches, toothpaste tubes, sachets – has called on the world’s biggest FMCG companies to support investment in new processing capacity.

    Enval CEO Dr Carlos Ludlow-Palafox has written an open letter addressed to the CEOs of companies that benefit from laminate packaging, such as Unilever, Kraft, Nestlé Mars, Colgate, Campbell’s, GSK and Hain-Celestial to get behind efforts to process post-consumer waste.

    Across Europe and the US, billions of plastic aluminium laminate pouches, tubes and sachets are being discarded and sent to landfill or incineration while consumers are often misled into thinking that they are recycled, as reported.

    In the UK alone more than 10 billion laminate packaging items are sold annually but fewer than 1 in 20,000 is recycled. Of the remainder two thirds go to landfill and the rest are incinerated. This recycling rate is 50 times worse than that of disposable coffee cups, which has received great attention from media and politicians alike.

    Because the material contains bonded plastic and aluminium, the packages cannot be treated either as plastic or as aluminium. Only the Enval process can deal with them, however currently there are no major initiatives in place in the UK or the world to collect and sort post-consumer packages and genuinely recycle them.

    To process the waste, Enval has developed the world’s only commercial scale plant to deal with the material, which uses a microwave heating method to recover the aluminium into reusable ingots and process the plastic into reclaimed oil.

    Manufacturers and waste companies have undertaken successful trials with the Enval plant but have failed to support wider collection and processing efforts due to a reluctance to make the initial investment required.

    Enval CEO Dr Ludlow-Palafox said the lack of involvement by the FMCG brand owners and the risk-averse nature of the waste handling sector has meant the Huntingdon plant is still the only one in operation.

    “We believe the time for complacency is over. FMCG brands are using laminate packaging because of its exceptional characteristics and cost and environmental benefits. Yet the fact remains that more than 10 billion pouches, tubes and sachets end up being thrown away in the UK alone. This is inexcusable now that we have an environmentally sustainable and economically viable solution. These same companies boast about their environmental credentials: it is time for some action.

    “Consumers are buying laminate packaging in good faith – often either thinking it can be recycled or because there is no other choice. Big brands have reaped the benefits of advancements in packaging technology while delivering no certainty to consumers.

    “The problem of single-use laminates dwarfs that of coffee cups. Brands and regulators now need to put their money where their mouth is and ensure that laminates can be genuinely reprocessed and these materials brought into a circular economy that benefits both the market and the planet.”

    Independent studies commissioned by WRAP UK and the UK’s Department for Environment, Food and Rural Affairs (DEFRA) have shown that laminates can be readily separated from waste streams using conventional sorting technology. These studies also proved that a majority of householders, when asked, sort laminates for recycling for collection as they do with other materials.

  • GSK Shopper Science Lab opens in Singapore

    GSK Shopper Science Lab opens in Singapore

    A new GSK Shopper Science Lab opened in Singapore will help drive business growth across Asia-Pacific, the company says.

    GlaxoSmithKline (GSK) Consumer Healthcare describes the research centre as a “cutting edge facility” which will deliver unique shopper insights and collaborations with retailers.

    “The Shopper Science Lab is a world-class shopper insight facility, equipped with state-of-the-art digital technology. With virtual reality, eye-tracking, facial biometrics, and data visualisation as some of the tools employed in-house, GSK will invite its trade partners, internal business teams and researchers to use the Lab to recreate retail environments; evaluate shoppers’ responses to online and in-store initiatives; and identify winning strategies and initiatives to enhance the shopping experience,” the company said in a statement.

    “As more shoppers join the global middle class, there is an increased demand for trusted, global brands particularly in the emerging markets. The GSK Shopper Science Lab has close proximity to large emerging markets like India and China, enabling GSK and its retail partners to study diverse emerging shoppers closely, with local data collected on the ground.”

    The GSK Shopper Science Lab consists of three labs integrated seamlessly:

    • A 1215 sqft Retail Lab, an immersive retail environment that allows the re-creation of modern and traditional retail environments such as a pharmacy or supermarket, allowing GSK and its partners to quickly test and evaluate shopper responses.
    • A Digital Lab which is a collaborative space which has the ability to test stimuli such as pack designs, point-of-sale materials, brand assets, TVCs, or content across all platforms.
    • A Collaboration Room, which provides a space to convene key decision makers, enabling them to embark on virtual and fully interactive simulations that include relevant data for faster and more informed decision making.

    “Traditional market research is often time-consuming and expensive,” explained Sidharth Singh, VP of commercial excellence, GSK Consumer Healthcare Asia, Middle East and Africa. “By leveraging the latest advances in virtual reality and biometric technology, we are now able to gather insights more efficiently and effectively.”

    An example of such technology is eye-tracking glasses which can be transported to various cities to provide researchers with an indication of how shoppers shop locally. Technology such as virtual reality, tracking sensors and software that can decode the hotspots, can help analyse this highly localised data to understand shopper behaviour in diverse markets.